Science magazine publishes the top 20 companies with the best biotechnology employers in 2019

Science released the 17th annual survey of the best employers in the field of biotechnology on May 25: Top 20 companies with the best employers in biotechnology in 2019, including many familiar biopharmaceutical giants such as Roche, AstraZeneca, Novartis, Pfizer and Merck (attached) The survey received more than 7500 responses About 95% of the respondents work in biotechnology and pharmaceutical industry About 80% of the respondents are aged 30 or over The proportion of respondents from North America has increased slightly, from 63% last year to 72% The proportion of respondents from Europe has decreased from 24% last year to 19% The proportion of respondents from Asia Pacific region has increased from 9% last year Down to 7% Surprisingly, the biotech company, Alnylam pharmaceuticals, was on the list for the first time! Headquartered in Cambridge, Massachusetts, USA, with more than 1200 employees, the company is a leading enterprise in the field of RNAi treatment drug development Last August, onpattro of Alnylam pharmaceutical passed the approval of the U.S FDA, becoming the first RNAi drug in the world for the treatment of patients with HTTR amyloidosis associated with polyneuropathy 5 Ten thousand people are affected by this rare and potentially fatal disease As a result, Alnylam pharmaceutical has also become a pioneer in bringing this brand-new drug to the market, and is the first to use this technology in clinical trials In the past three years, regeneron pharmaceuticals, a New York based biopharmaceutical company, ranked No 1, and this year, regeneron pharmaceuticals dropped to No 2 However, it also reflects that innovation is still the top priority of life science respondents Nowadays, the industry has changed dramatically in terms of drug pricing, regulations and policies, and the political environment, regulators, pricing pressures, artificial intelligence, machine learning and other factors have a great impact on the industry Some head office employees expressed their views on similar issues, describing how their organizations maintain innovative advantages and excellent working environment, and more and more use of artificial intelligence to influence work and work culture Here's another company on the list, spark therapeutics The company, like Alnylam pharmaceuticals, is also the first to make the list, ranking fifth this year Spark company was founded in 2013, headquartered in Philadelphia, Pennsylvania, USA, with more than 400 employees On December 19, 2017, luxturna of spark company became the first ophthalmic gene therapy drug officially approved by FDA for the treatment of rare genetic blindness visual loss Currently, spark company has several gene therapy drugs in clinical trials On February 25 this year, biopharmaceutical giant Roche and spark therapeutics announced that they have reached a final acquisition agreement Roche will purchase spark therapeutics as a whole in cash at a price of $114.50 per share On the basis of complete dilution, the total price of this acquisition is about $4.3 billion, which is higher than that of spark therapeutics on February 22, 2019 Day's closing price premium is about 122% In this survey by science, spark employees are positive about the acquisition, saying it's a good thing to be acquired by Roche, the world's top drug development company, and they can get additional funds to promote their own research and development According to the latest news today, Roche has extended the offer to November 25, which will give regulators in the United States and the United Kingdom more time to sign merger agreements Roche and its subsidiary Genentech are also on science's Best Employers list, and Genentech is the only company that has been on the list since the list was established in 2002, which can be called the company standard of biotechnology industry.